1. Home
  2. ROCK vs SLNO Comparison

ROCK vs SLNO Comparison

Compare ROCK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$50.57

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$48.31

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
SLNO
Founded
1972
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.5B
IPO Year
1993
2014

Fundamental Metrics

Financial Performance
Metric
ROCK
SLNO
Price
$50.57
$48.31
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$110.90
AVG Volume (30 Days)
345.6K
1.6M
Earning Date
10-30-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$1,383,811,000.00
$98,675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.98
$155.86
P/E Ratio
$11.17
N/A
Revenue Growth
23.49
N/A
52 Week Low
$42.86
$41.50
52 Week High
$75.08
$90.32

Technical Indicators

Market Signals
Indicator
ROCK
SLNO
Relative Strength Index (RSI) 41.35 42.58
Support Level $50.00 $48.60
Resistance Level $51.96 $50.95
Average True Range (ATR) 1.51 2.63
MACD 0.60 0.21
Stochastic Oscillator 32.81 9.24

Price Performance

Historical Comparison
ROCK
SLNO

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: